Dr. Adarsh Vennepureddy
Claim this profileAultman Health Foundation
Studies Colorectal Cancer
Studies Colon Cancer
9 reported clinical trials
30 drugs studied
Area of expertise
1Colorectal Cancer
Stage III
Stage II
MLH1 positive
2Colon Cancer
Stage III
Stage II
MLH1 positive
Affiliated Hospitals
Clinical Trials Adarsh Vennepureddy is currently running
Selumetinib + Olaparib
for Ovarian and Endometrial Cancer
This phase II ComboMATCH treatment trial compares selumetinib plus olaparib to selumetinib alone in women with endometrial or ovarian (fallopian tube and primary peritoneal) cancer that has come back (recurrent) or that remains despite treatment (persistent) and harbors a mutation in the RAS pathway. Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. The addition of olaparib to selumetinib could increase the percentage of tumors that shrink as well as lengthen the time that the tumors remain stable (without progression) as compared to selumetinib alone.
Recruiting1 award Phase 2
Ipatasertib + Chemotherapy
for Cancer
This phase II ComboMATCH treatment trial tests the usual treatment of chemotherapy (paclitaxel) plus ipatasertib in patients with solid tumor cancers that that cannot be removed by surgery (unresectable), has spread to nearby tissue or lymph nodes (locally advanced) or from where it first started (primary site) to other places in the body (metastatic), and has PTEN and AKT genetic changes. Chemotherapy drugs, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Targeted therapy, such as Ipatasertib, may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. The addition of ipatasertib to paclitaxel in solid tumors with PTEN and AKT genetic changes could increase the percentage of tumors that shrink as well as lengthen the time that the tumors remain stable (without progression). Researchers hope to learn if paclitaxel plus ipatasertib will shrink this type of cancer or stop its growth.
Recruiting1 award Phase 2
More about Adarsh Vennepureddy
Clinical Trial Related2 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Adarsh Vennepureddy has experience with
- Binimetinib
- Fulvestrant
- Paclitaxel
- Oxaliplatin
- Selumetinib Sulfate
- Ipatasertib
Breakdown of trials Adarsh Vennepureddy has run
Colorectal Cancer
Fallopian Tube Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Adarsh Vennepureddy specialize in?
Adarsh Vennepureddy focuses on Colorectal Cancer and Colon Cancer. In particular, much of their work with Colorectal Cancer has involved Stage III patients, or patients who are Stage II.
Is Adarsh Vennepureddy currently recruiting for clinical trials?
Yes, Adarsh Vennepureddy is currently recruiting for 3 clinical trials in Canton Ohio. If you're interested in participating, you should apply.
Are there any treatments that Adarsh Vennepureddy has studied deeply?
Yes, Adarsh Vennepureddy has studied treatments such as Binimetinib, Fulvestrant, Paclitaxel.
What is the best way to schedule an appointment with Adarsh Vennepureddy?
Apply for one of the trials that Adarsh Vennepureddy is conducting.
What is the office address of Adarsh Vennepureddy?
The office of Adarsh Vennepureddy is located at: Aultman Health Foundation, Canton, Ohio 44710 United States. This is the address for their practice at the Aultman Health Foundation.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.